ADMA Biologics Inc. (ADMA)
ADMA Biologics Max Pain By Strike
ADMA trades at $16.42, 3.4% below the near-term max pain of $17 expiring Sep 19, 2025 (11 days). Price stability likely with balanced options positioning at this level. Max pain is rising across expirations ($15-$19), reflecting growing call interest at higher strikes. Key magnetic zone at 15 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
ADMA Biologics Max Pain By Expiry
Max pain for ADMA shows an upward trend from 15 to 19, suggesting bullish positioning in longer-dated options. The 24% spread signals divergent expectations across timeframes. Levels distributed around 16.42. Strong magnetic level at 15 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 17 | 0.58 (3.53%) |
| Oct 17, 2025 | 17 | 0.58 (3.53%) |
| Nov 21, 2025 | 19 | 2.58 (15.71%) |
| Jan 16, 2026 | 19 | 2.58 (15.71%) |
| Feb 20, 2026 | 16 | -0.42 (-2.56%) |
| Mar 20, 2026 | 16 | -0.42 (-2.56%) |
| Apr 17, 2026 | 15 | -1.42 (-8.65%) |
| Jun 18, 2026 | 15 | -1.42 (-8.65%) |
| Jan 15, 2027 | 15 | -1.42 (-8.65%) |